Trexquant Investment’s Maravai LifeSciences MRVI Stock Holding History

Trexquant Investment’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$436K	Buy	+69,861	New	+$302K	﹤0.01%	1670
2024 Q4	–	Sell	-251,299	Closed	-$2.09M	–	1750
2024 Q3	$2.09M	Sell	251,299 -404,248	-62%	-$3.49M	0.03%	793
2024 Q2	$4.69M	Buy	655,547 +223,998	+52%	+$1.93M	0.07%	424
2024 Q1	$3.74M	Buy	+431,549	New	+$2.92M	0.07%	412
2023 Q2	–	Sell	-108,458	Closed	-$1.52M	–	1660
2023 Q1	$1.52M	Buy	+108,458	New	+$1.56M	0.04%	562
2022 Q2	–	Sell	-23,548	Closed	-$831K	–	1732
2022 Q1	$831K	Sell	23,548 -132,620	-85%	-$4.45M	0.04%	549
2021 Q4	$6.54M	Buy	+156,168	New	+$6.33M	0.4%	41
2021 Q3	–	Sell	-19,511	Closed	-$814K	–	1359
2021 Q2	$814K	Buy	+19,511	New	+$756K	0.07%	356

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Trexquant Investment's MRVI Position: Q2 2026 in Review

Trexquant Investment opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 69,861 shares worth $436K. The stake represents ﹤0.01% of the portfolio and ranks #1670 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in MRVI as recently as Q3 2024.

Trexquant Investment first reported a position in MRVI in Q2 2021 and has held it in 8 quarters since. The position peaked at $6.54M in Q4 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Trexquant Investment held 69,861 shares of Maravai LifeSciences worth $436K as of Q2 2026.
Maravai LifeSciences was a new Trexquant Investment position in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1670 holding.
Trexquant Investment first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 8 quarters since.
Trexquant Investment's Maravai LifeSciences position peaked at $6.54M in Q4 2021.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.